MEDICUS PHARMA LTD. Public Float
MEDICUS PHARMA LTD. (MDCX) had Public Float of $28.30 million as of 2025-06-30, per its 10-K/A filed 2026-04-29.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-29
- 2025-06-30: Entity Public Float $28.30M.
- 2024-06-30: Entity Public Float $28.30M; Entity Public Float as first filed $11.20M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $28.30M 10-K/A · filed 2026-04-29 | |
| 2024-06-30 | $28.30M 10-K · filed 2026-03-25 | $11.20M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |